Dr Ned Hoyle

Ned is a molecular biologist with a passion for translating complex science into impactful therapeutics. As Associate Director of Biology at ViaNautis and RNA Platform Lead at Camgene Therapeutics, he has led the development of genetic medicines from concept to preclinical milestones. His career spans roles across biotech innovation, including scientific positions at PhoreMost and postdoctoral research at leading UK institutes. With over a dozen scientific publications—including in Nature and Science Translational Medicine—Ned’s expertise lies in gene therapy, RNA design, and quantitative cell biology. His foundation in translational control and splicing has shaped a career focused on next-generation therapeutic platforms.